Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-10-25 00:00:00 ET · period of report 2022-10-21 · accession 0000899243-22-034121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-25 | 2022-10-21 | BDTX | BB BIOTECH AG | 10% | P - Purchase | $1.51 | +87.8K | 4.91M | +2% | +$132.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-21 | P | A | 87,850 | $1.51 | 4,913,386 | D | — | — |